Suchergebnisse - "Menzies-Gow, Andrew"

PubPharm (247)

51

A Response to : Letter to the Editor Regarding "Clinical Remission in Severe Asthma: A Pooled Post Hoc Analysis of the Patient Journey with Benralizumab"

enthalten in: Advances in therapy | 2022

von Menzies-Gow, A. | Hoyte, F. | Price, D. | +7

CommentOn: Adv Ther. 2022 May;39(5):2065-2084. - PMID 35287231

52

The carbon footprint of respiratory treatments in Europe and Canada : an observational study from the CARBON programme

enthalten in: The European respiratory journal | 2022

von Janson, C. | Maslova, E. | Wilkinson, A. | +7

53

Evaluation of the oral corticosteroid-sparing effect of tezepelumab in adults with oral corticosteroid-dependent asthma (SOURCE) : a randomised, placebo-controlled, phase 3 study

enthalten in: The Lancet. Respiratory medicine | 2022

von Wechsler, M. | Menzies-Gow, A. | Brightling, C. | +72

ErratumIn: Lancet Respir Med. 2022 Apr 5;:. - PMID 35395206

54

A Response to: Letter to the Editor Regarding “Clinical Remission in Severe Asthma: A Pooled Post Hoc Analysis of the Patient Journey with Benralizumab”

enthalten in: Advances in therapy | 2022

von Menzies-Gow, A. | Hoyte, F. | Price, D. | +7

55

A Response to: Letter to the Editor Regarding “Clinical Remission in Severe Asthma: A Pooled Post Hoc Analysis of the Patient Journey with Benralizumab”

enthalten in: Advances in therapy | 2022

von Menzies-Gow, A. | Hoyte, F. | Price, D. | +7

56

A Response to: Letter to the Editor Regarding “Clinical Remission in Severe Asthma: A Pooled Post Hoc Analysis of the Patient Journey with Benralizumab”

enthalten in: Advances in therapy | 2022

von Menzies-Gow, A. | Hoyte, F. | Price, D. | +7

57

Benralizumab Effectiveness in Severe Asthma Is Independent of Previous Biologic Use

enthalten in: The journal of allergy and clinical immunology. In practice | 2022

von Jackson, D. | Burhan, H. | Menzies-Gow, A. | +7

58

Investigational approaches for unmet need in severe asthma

enthalten in: Expert review of respiratory medicine | 2022

von Watchorn, D. | Menzies-Gow, A.

59

Global Variability in Administrative Approval Prescription Criteria for Biologic Therapy in Severe Asthma

enthalten in: The journal of allergy and clinical immunology. In practice | 2022

von Porsbjerg, C. | Menzies-Gow, A. | Tran, T. | +56

ErratumIn: J Allergy Clin Immunol Pract. 2022 Jun;10(6):1673. - PMID 35688511

60

Clinical Remission in Severe Asthma : A Pooled Post Hoc Analysis of the Patient Journey with Benralizumab

enthalten in: Advances in therapy | 2022

von Menzies-Gow, A. | Hoyte, F. | Price, D. | +7

CommentIn: Adv Ther. 2022 Aug;39(8):3857-3861. - PMID 35731338